DashboardAll companies
Run this on your own research
Industrials · Aerospace & Defense

General Electric Company

GENYSE$285.64−$7.90 (−2.69%)Market closed

Price Chart

Daily

Key facts

Market Cap
$297.07B
P/E
34.8x
P/B
16.23x
ROE
45.8%

General Electric Company

Industrials · Aerospace & Defense · FY 2025

General Electric Company is a multinational conglomerate known for its extensive influence across various sectors, particularly in aviation, healthcare, renewable energy, and power. Primarily, General Electric designs and produces a wide array of products and technologies essential to infrastructure and industry. This includes engines for commercial and military aircraft, medical imaging equipment, wind turbines, and energy-efficient lighting solutions. The company’s healthcare segment significantly contributes to global medical advancements, offering critical technologies like MRI machines and ultrasound devices. Meanwhile, its renewable energy division champions sustainable initiatives, including offshore and onshore wind projects, contributing to a cleaner global energy landscape. Established in 1892 and headquartered in Boston, Massachusetts, General Electric's role in the financial market is noteworthy for its century-spanning innovation and adaptation. It remains a pivotal player in both traditional and emerging sectors, leveraging its diversified portfolio to meet the evolving demands of modernization and sustainability.

CEO
Mr. H. Lawrence Culp Jr.
Employees
53,000

Company Statistics

Valuation

P/E
34.8x
P/B
16.23x
P/S
6.61x
EV/EBITDA
25.6x
P/FCF
41.7x

Margins

Gross
31.5%
EBITDA
26.5%
Operating
18.9%
Pre-Tax
21.8%
Net
19.0%

Returns

ROA
6.9%
ROE
45.8%
ROIC
8.6%

Growth (CAGR)

Rev 3Yr
−7.6%
Rev 5Yr
−9.6%
Op Inc 3Yr
215.6%
Net Inc 3Yr
177.5%

Financial Health

Cash & Cash Equivalents
$12.39B
Net Debt
$98.88B
Debt/Equity
588.8%
Interest Cov
—

Profile

Revenue
$45.86B
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
General Electric Company (GE) Stock Forecast 2026 $285.64 — Price, Financials & Analyst Targets | AlphaLenz